Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ponatinib Consolidation for TFR in CML
NCT04043676Phase 2Unknown
- Sponsor
- Fundación Teófilo Hernando
- Start
- Apr 2019
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ponatinib in chronic myeloid leukemia (CML), sponsored by Fundación Teófilo Hernando. Status: unknown.
02
Drugs
ponatinib
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT04043676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04043676.